Video : How Drug Eluting Technologies will revolutionize your practice?

It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Endovascular / Lower limbs / Fempop / Live

My Player placeholder

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login

Worldwide schedules comment Share

20264 views

The treatment of Peripheral Artery Disease (PAD) has known an important evolution in the last years. An important limitation of current endovascular therapy remains the occurrence of restenosis. In order to minimize restenosis rates, Drug-Eluting Technologies (DET) are evolving. The use of drug-eluting stents (DES) in coronary arteries shows beneficial results, leading to investigation of DES in PAD.

In this web symposium, we give an overview of current available data on PAD treatment with drug eluting technologies.
Through video cases performed by expert operators, discover techniques and devices to improve the use of DET in your daily practice.

Program

Debate with our experts : How Drug Eluting Technologies will revolutionize your practice?

1st case : Calcified left SFA - Double access ( Antegrade + Retrograde)

How to use DET based on clinical data review in 2016? – Lecture by Dr Thomas Zeller

2nd case : Polystenotic calcified right SFA Antegrade approach - DES and DEB combination therapy

Eluvia, designing a revolutionary drug eluting stent for SFA interventions – Lecture by Jaydeep Kokate

3rd case : Short left superficial femoral artery Eluvia stenting

My experience in DET : indications and algorythm - Lecture by Dr Koen Deloose

Educational objectives

Discuss current trends and approaches to the treatment of PAD with the use of DET, in terms of patient’s outcomes
Demonstrate advanced techniques and new drug eluting technologies in the treatment of peripheral artery disease
Provide platform for discussion and mutual learning

Audience

Endovascular specialists (Vascular Surgeons, Interventional Radiologists, Interventional Angiologists and Interventional Cardiologists)
Referring physicians of patients with peripheral artery disease

Shooting date : 2016-07-13
Last update : 2021-06-09